Wrap Technologies raises $5M to restart manufacturing

Wrap Technologies (WRAP) entered into a securities purchase agreement for a $5M private placement. The capital raise is expected to enable the Company to restart domestic manufacturing, advance validated R&D programs into commercialization, and responsibly accelerate early growth initiatives aligned with rising demand for non-lethal response capabilities. Wrap is restarting domestic manufacturing with a renewed focus on rigorous quality control standards for its Non-Lethal Response technologies. This is expected to include the return of experienced quality and production personnel who were integral to earlier high-reliability manufacturing runs, as well as the reimplementation of proven inspection, testing, and process controls. These efforts reflect the Company’s emphasis on precision, durability, and consistency as it prepares for expanded deployments across domestic and federal markets. In parallel, Wrap is increasing domestic training capacity to support broader adoption of Non-Lethal Response programs. Training is expected to be delivered through a tiered model that includes lead instructors, train-the-trainer certification, and hybrid delivery combining in-person and digital instruction for all operators of its expanded Non-Lethal Response technologies. The training expansion is expected to focus on operational integration, lawful control, and scenario-based readiness, ensuring agencies may have the opportunity to deploy non-lethal tools effectively and safely in real-world conditions.